Bio Therapeutic Drugs Businesses for Sale and Investment Opportunities in India

- We do the R&D for big pharma companies. - Innovative formulation development with a focus on quality-by-design principles for precise and effective therapeutic solutions. - Commitment to excellence reflected in crafting products that redefine healthcare standards. - Fusion of innovation and precision, guided by scientific rigor, transforming pharmaceutical science into life-changing solutions. - Expertise in product development, CDMO, CMO, and TT services for five major clients, including big pharma companies. - Promoters bring 15 years of experience in R&D and product development. - Client base includes European companies, demonstrating international reach. - Regulatory approvals from the FDA and ISO 17025 underscore the company's commitment to quality and compliance. - Adaptive workforce with contract workers based on demand. - High growth attributed to the acquisition of new clients, showcasing the company's expanding market presence.

We have launched 15 innovative products. The products are planned for sales through omni channel marketing. We have presence in general trade and ecommerce. We need to enter into exports, modern trade and multiple market places. .

- We are a biopharma company dealing in the research and development of various formulations and clinical trials. - As of now the company has rights of 15 formulations and has a large market share in this industry. - Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology. - These patients especially travel to India for our treatments. - We don't have our own clinics but subcontract hospitals in Mumbai to use our technology. - Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them. - We also have discussions going on with various insurance companies to provide coverage for our treatments. - Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there. - This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets. - The company has two partners with a 70% and 30% stake distribution. - Business has not taken any loans previously. - We are seeking investment to establish the manufacturing unit.